Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastomaJasmine Y. Lee(Emory University), Kelly C. Goldsmith(Children's Healthcare of Atlanta)Cell Reports MedicineJune 1, 202310.1016/j.xcrm.2023.101091Cited by 16SaveCiteExport RISWatch citationsRelated PapersSelect Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma|BMC Cancer|2016|38